Garcia S, Monserrat-Mesquida M, Ugarriza L, Casares M, Gomez C, Mateos D
Nutrients. 2025; 17(3).
PMID: 39940330
PMC: 11820933.
DOI: 10.3390/nu17030472.
Lu J, Chen Y, Huang Y
World J Gastroenterol. 2025; 31(5):102047.
PMID: 39926217
PMC: 11718616.
DOI: 10.3748/wjg.v31.i5.102047.
Li C, Yao J, Yang C, Yu S, Yang Z, Wang L
Metab Brain Dis. 2025; 40(2):122.
PMID: 39921774
DOI: 10.1007/s11011-025-01554-5.
Li J, Lv M, Yuan Z, Ge J, Geng T, Gong D
Poult Sci. 2024; 104(1):104617.
PMID: 39644719
PMC: 11667692.
DOI: 10.1016/j.psj.2024.104617.
Korkmaz O, Saydam F, Dalkiran B, Degirmenci I, Tuncel N
Cell Biochem Biophys. 2024; .
PMID: 39550744
DOI: 10.1007/s12013-024-01606-0.
Cotinine exposure enhances the association of blood manganese and non-alcoholic fatty liver disease in American children: a cross-sectional study.
Zhang L, Wei H, Lin S, Qiu B, Lin J
Sci Rep. 2024; 14(1):24593.
PMID: 39426991
PMC: 11490505.
DOI: 10.1038/s41598-024-75298-0.
Metabolic Syndrome Severity Predicts Mortality in Nonalcoholic Fatty Liver Disease.
Elsaid M, Bridges J, Li N, Rustgi V
Gastro Hep Adv. 2024; 1(3):445-456.
PMID: 39131673
PMC: 11308509.
DOI: 10.1016/j.gastha.2022.02.002.
Molybdenum's Role as an Essential Element in Enzymes Catabolizing Redox Reactions: A Review.
Adamus J, Ruszczynska A, Wyczalkowska-Tomasik A
Biomolecules. 2024; 14(7).
PMID: 39062583
PMC: 11275037.
DOI: 10.3390/biom14070869.
Association of GCKR and MBOAT7 genetic polymorphisms with non-alcoholic fatty liver disease.
Chavan S, Rathi P, Mandot A
Clin Exp Hepatol. 2024; 10(1):39-46.
PMID: 38765903
PMC: 11100339.
DOI: 10.5114/ceh.2024.136326.
Cell senescence in liver diseases: pathological mechanism and theranostic opportunity.
Sanfeliu-Redondo D, Gibert-Ramos A, Gracia-Sancho J
Nat Rev Gastroenterol Hepatol. 2024; 21(7):477-492.
PMID: 38485755
DOI: 10.1038/s41575-024-00913-4.
Exploring the interplay of gut microbiota, inflammation, and LDL-cholesterol: a multiomics Mendelian randomization analysis of their causal relationship in acute pancreatitis and non-alcoholic fatty liver disease.
Yan C, Bao J, Jin J
J Transl Med. 2024; 22(1):179.
PMID: 38374155
PMC: 10875775.
DOI: 10.1186/s12967-024-04996-0.
Clinical Profile of Nonalcoholic Fatty Liver Disease and its Correlation with Metabolic Syndrome and Cardiovascular Risk.
Vakil Z, Ahire K
Int J Appl Basic Med Res. 2024; 13(4):234-239.
PMID: 38229733
PMC: 10789464.
DOI: 10.4103/ijabmr.ijabmr_138_23.
Gender perspective on the association between liver enzyme markers and non-alcoholic fatty liver disease: insights from the general population.
Qiu J, Kuang M, He S, Yu C, Wang C, Huang X
Front Endocrinol (Lausanne). 2023; 14:1302322.
PMID: 38125795
PMC: 10731038.
DOI: 10.3389/fendo.2023.1302322.
Parental History of Type 2 Diabetes Mellitus and PNPLA3 Polymorphism Increase the Risk of Severe Stages of Nonalcoholic Fatty Liver Disease.
Wajsbrot N, Leite N, Franca P, Lopes Cardoso C, Salles G, Villela-Nogueira C
Dig Dis Sci. 2023; 69(2):634-642.
PMID: 38112841
DOI: 10.1007/s10620-023-08214-7.
Crosstalk between bone and other organs.
Yuan W, Song C
Med Rev (2021). 2023; 2(4):331-348.
PMID: 37724328
PMC: 10471111.
DOI: 10.1515/mr-2022-0018.
Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Persons with Type 2 Diabetes Mellitus in Ghana: A Study of Prevalence, Severity, and Contributing Factors Using Transient Elastography.
Wiafe Y, Afihene M, Anto E, Nmai R, Amoah-Kumi L, Frimpong J
J Clin Med. 2023; 12(11).
PMID: 37297935
PMC: 10253760.
DOI: 10.3390/jcm12113741.
β-sitosterol attenuates high- fat diet-induced hepatic steatosis in rats by modulating lipid metabolism, inflammation and ER stress pathway.
Abo-Zaid O, Moawed F, Ismail E, Farrag M
BMC Pharmacol Toxicol. 2023; 24(1):31.
PMID: 37173727
PMC: 10182633.
DOI: 10.1186/s40360-023-00671-0.
Prevalence of non-alcoholic fatty liver disease among diabetes, prediabetes and healthy population.
Kumar P, Rawat S, Kakar A, Sinha A
J Family Med Prim Care. 2023; 11(12):7640-7643.
PMID: 36994063
PMC: 10041021.
DOI: 10.4103/jfmpc.jfmpc_856_22.
Role of Nutrition in the Etiopathogenesis and Prevention of Nonalcoholic Fatty Liver Disease (NAFLD) in a Group of Obese Adults.
Metro D, Buda M, Manasseri L, Corallo F, Cardile D, Lo Buono V
Medicina (Kaunas). 2023; 59(3).
PMID: 36984639
PMC: 10055888.
DOI: 10.3390/medicina59030638.
Impaired Function of Solute Carrier Family 19 Leads to Low Folate Levels and Lipid Droplet Accumulation in Hepatocytes.
Cano A, Vazquez-Chantada M, Conde-Vancells J, Gonzalez-Lahera A, Mosen-Ansorena D, Blanco F
Biomedicines. 2023; 11(2).
PMID: 36830876
PMC: 9953281.
DOI: 10.3390/biomedicines11020337.